NTRK1 and cancer: Given that TrkA was not expressed in most adenocarcinomas and small cell lung cancers, the area under the receiver-operating characteristic (AUROC) for the comparison between normal and cancer samples was only 0.39 (95%CI 0.32 to 0.46) (data not shown).